Atlas Trials

Evaluation of QTc Interval

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Evaluation of QTc Interval

RecordFirmDate
An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA® in Opioid Dependent Subjects. (NCT04088266)Teva Pharmaceuticals USA2020-01-01

Track Evaluation of QTc Interval automatically

Every clearance here is in the API, with alerts when new ones post.